ORGANOGENESIS HOLDINGS INC (ORGO) Fundamental Analysis & Valuation

NASDAQ:ORGO • US68621F1021

Current stock price

2.38 USD
+0.09 (+3.93%)
At close:
2.36 USD
-0.02 (-0.84%)
After Hours:

This ORGO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ORGO Profitability Analysis

1.1 Basic Checks

  • ORGO had positive earnings in the past year.
  • ORGO had a negative operating cash flow in the past year.
  • Of the past 5 years ORGO 4 years were profitable.
  • Of the past 5 years ORGO 4 years had a positive operating cash flow.
ORGO Yearly Net Income VS EBIT VS OCF VS FCFORGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M

1.2 Ratios

  • ORGO's Return On Assets of 2.65% is amongst the best of the industry. ORGO outperforms 88.78% of its industry peers.
  • ORGO has a better Return On Equity (3.65%) than 89.94% of its industry peers.
  • The Return On Invested Capital of ORGO (8.83%) is better than 92.26% of its industry peers.
  • ORGO had an Average Return On Invested Capital over the past 3 years of 5.16%. This is significantly below the industry average of 27.63%.
  • The 3 year average ROIC (5.16%) for ORGO is below the current ROIC(8.83%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.65%
ROE 3.65%
ROIC 8.83%
ROA(3y)1.41%
ROA(5y)5.82%
ROE(3y)2.05%
ROE(5y)10.24%
ROIC(3y)5.16%
ROIC(5y)7.22%
ORGO Yearly ROA, ROE, ROICORGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

  • With an excellent Profit Margin value of 2.81%, ORGO belongs to the best of the industry, outperforming 88.59% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ORGO has declined.
  • ORGO has a Operating Margin of 9.90%. This is amongst the best in the industry. ORGO outperforms 90.33% of its industry peers.
  • ORGO's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 75.62%, ORGO belongs to the top of the industry, outperforming 83.17% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ORGO has remained more or less at the same level.
Industry RankSector Rank
OM 9.9%
PM (TTM) 2.81%
GM 75.62%
OM growth 3Y26.04%
OM growth 5Y4.64%
PM growth 3Y1.07%
PM growth 5Y-6.94%
GM growth 3Y-0.48%
GM growth 5Y0.38%
ORGO Yearly Profit, Operating, Gross MarginsORGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ORGO Health Analysis

2.1 Basic Checks

  • ORGO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • ORGO has more shares outstanding than it did 1 year ago.
  • ORGO has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ORGO has a worse debt to assets ratio.
ORGO Yearly Shares OutstandingORGO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ORGO Yearly Total Debt VS Total AssetsORGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • ORGO has an Altman-Z score of 2.84. This is not the best score and indicates that ORGO is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ORGO has a better Altman-Z score (2.84) than 67.31% of its industry peers.
  • A Debt/Equity ratio of 0.03 indicates that ORGO is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.03, ORGO is in line with its industry, outperforming 43.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 2.84
ROIC/WACC0.97
WACC9.12%
ORGO Yearly LT Debt VS Equity VS FCFORGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • ORGO has a Current Ratio of 3.62. This indicates that ORGO is financially healthy and has no problem in meeting its short term obligations.
  • ORGO has a Current ratio (3.62) which is comparable to the rest of the industry.
  • ORGO has a Quick Ratio of 3.32. This indicates that ORGO is financially healthy and has no problem in meeting its short term obligations.
  • ORGO has a Quick ratio of 3.32. This is comparable to the rest of the industry: ORGO outperforms 42.55% of its industry peers.
Industry RankSector Rank
Current Ratio 3.62
Quick Ratio 3.32
ORGO Yearly Current Assets VS Current LiabilitesORGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ORGO Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 52.94% over the past year.
  • Measured over the past years, ORGO shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.72% on average per year.
  • ORGO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.04%.
  • ORGO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.77% yearly.
EPS 1Y (TTM)52.94%
EPS 3Y25.99%
EPS 5Y16.72%
EPS Q2Q%416.67%
Revenue 1Y (TTM)17.04%
Revenue growth 3Y7.76%
Revenue growth 5Y10.77%
Sales Q2Q%78.13%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.92% on average over the next years. This is quite good.
  • Based on estimates for the next years, ORGO will show a decrease in Revenue. The Revenue will decrease by -0.44% on average per year.
EPS Next Y-109.81%
EPS Next 2Y12.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-21.5%
Revenue Next 2Y-0.44%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ORGO Yearly Revenue VS EstimatesORGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ORGO Yearly EPS VS EstimatesORGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

4

4. ORGO Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.15, the valuation of ORGO can be described as very reasonable.
  • Based on the Price/Earnings ratio, ORGO is valued cheaply inside the industry as 97.29% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.78. ORGO is valued rather cheaply when compared to this.
  • The Forward Price/Earnings Ratio is negative for ORGO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 9.15
Fwd PE N/A
ORGO Price Earnings VS Forward Price EarningsORGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

  • 98.65% of the companies in the same industry are more expensive than ORGO, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3
ORGO Per share dataORGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • The decent profitability rating of ORGO may justify a higher PE ratio.
  • A more expensive valuation may be justified as ORGO's earnings are expected to grow with 12.92% in the coming years.
PEG (NY)N/A
PEG (5Y)0.55
EPS Next 2Y12.92%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ORGO Dividend Analysis

5.1 Amount

  • No dividends for ORGO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ORGO Fundamentals: All Metrics, Ratios and Statistics

ORGANOGENESIS HOLDINGS INC

NASDAQ:ORGO (4/10/2026, 8:00:02 PM)

After market: 2.36 -0.02 (-0.84%)

2.38

+0.09 (+3.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners54.15%
Inst Owner Change0%
Ins Owners32.49%
Ins Owner Change1.24%
Market Cap306.16M
Revenue(TTM)564.17M
Net Income(TTM)15.85M
Analysts85.71
Price Target8.16 (242.86%)
Short Float %18.69%
Short Ratio19.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)106.05%
Min EPS beat(2)44.72%
Max EPS beat(2)167.38%
EPS beat(4)2
Avg EPS beat(4)16.53%
Min EPS beat(4)-73%
Max EPS beat(4)167.38%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)19.19%
Min Revenue beat(2)10.3%
Max Revenue beat(2)28.08%
Revenue beat(4)2
Avg Revenue beat(4)6.94%
Min Revenue beat(4)-6.36%
Max Revenue beat(4)28.08%
Revenue beat(8)6
Avg Revenue beat(8)7.04%
Revenue beat(12)7
Avg Revenue beat(12)4.32%
Revenue beat(16)7
Avg Revenue beat(16)2.3%
PT rev (1m)-5.88%
PT rev (3m)-5.88%
EPS NQ rev (1m)-52.63%
EPS NQ rev (3m)-222.22%
EPS NY rev (1m)0%
EPS NY rev (3m)-117.24%
Revenue NQ rev (1m)-41.09%
Revenue NQ rev (3m)-56.57%
Revenue NY rev (1m)-14.36%
Revenue NY rev (3m)-26.17%
Valuation
Industry RankSector Rank
PE 9.15
Fwd PE N/A
P/S 0.54
P/FCF N/A
P/OCF N/A
P/B 0.71
P/tB 0.77
EV/EBITDA 3
EPS(TTM)0.26
EY10.92%
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS4.39
BVpS3.37
TBVpS3.08
PEG (NY)N/A
PEG (5Y)0.55
Graham Number4.44
Profitability
Industry RankSector Rank
ROA 2.65%
ROE 3.65%
ROCE 11.21%
ROIC 8.83%
ROICexc 10.88%
ROICexgc 12%
OM 9.9%
PM (TTM) 2.81%
GM 75.62%
FCFM N/A
ROA(3y)1.41%
ROA(5y)5.82%
ROE(3y)2.05%
ROE(5y)10.24%
ROIC(3y)5.16%
ROIC(5y)7.22%
ROICexc(3y)6.81%
ROICexc(5y)10.02%
ROICexgc(3y)7.75%
ROICexgc(5y)12.19%
ROCE(3y)6.54%
ROCE(5y)9.15%
ROICexgc growth 3Y14.91%
ROICexgc growth 5Y-14%
ROICexc growth 3Y18.93%
ROICexc growth 5Y-6.02%
OM growth 3Y26.04%
OM growth 5Y4.64%
PM growth 3Y1.07%
PM growth 5Y-6.94%
GM growth 3Y-0.48%
GM growth 5Y0.38%
F-Score2
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.17
Cap/Depr 76.1%
Cap/Sales 2.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.62
Quick Ratio 3.32
Altman-Z 2.84
F-Score2
WACC9.12%
ROIC/WACC0.97
Cap/Depr(3y)97.86%
Cap/Depr(5y)180.1%
Cap/Sales(3y)3.4%
Cap/Sales(5y)4.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.94%
EPS 3Y25.99%
EPS 5Y16.72%
EPS Q2Q%416.67%
EPS Next Y-109.81%
EPS Next 2Y12.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.04%
Revenue growth 3Y7.76%
Revenue growth 5Y10.77%
Sales Q2Q%78.13%
Revenue Next Year-21.5%
Revenue Next 2Y-0.44%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y159.64%
EBIT growth 3Y35.82%
EBIT growth 5Y15.91%
EBIT Next Year-3.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-685.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-172.56%
OCF growth 3YN/A
OCF growth 5YN/A

ORGANOGENESIS HOLDINGS INC / ORGO Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ORGANOGENESIS HOLDINGS INC?

ChartMill assigns a fundamental rating of 5 / 10 to ORGO.


What is the valuation status of ORGANOGENESIS HOLDINGS INC (ORGO) stock?

ChartMill assigns a valuation rating of 4 / 10 to ORGANOGENESIS HOLDINGS INC (ORGO). This can be considered as Fairly Valued.


Can you provide the profitability details for ORGANOGENESIS HOLDINGS INC?

ORGANOGENESIS HOLDINGS INC (ORGO) has a profitability rating of 7 / 10.


Can you provide the financial health for ORGO stock?

The financial health rating of ORGANOGENESIS HOLDINGS INC (ORGO) is 4 / 10.


What is the earnings growth outlook for ORGANOGENESIS HOLDINGS INC?

The Earnings per Share (EPS) of ORGANOGENESIS HOLDINGS INC (ORGO) is expected to decline by -109.81% in the next year.